448 related articles for article (PubMed ID: 20304645)
21. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents.
Mallikarjuna BP; Sastry BS; Suresh Kumar GV; Rajendraprasad Y; Chandrashekar SM; Sathisha K
Eur J Med Chem; 2009 Nov; 44(11):4739-46. PubMed ID: 19589626
[TBL] [Abstract][Full Text] [Related]
24. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
Siddiki AA; Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
Ali MA; Shaharyar M; Siddiqui AA
Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activities of new hydrazide derivatives.
Ozdemir A; Turan-Zitouni G; Kaplancikli ZA; Tunali Y
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):825-31. PubMed ID: 18825530
[TBL] [Abstract][Full Text] [Related]
31. Search of antitubercular activities in tetrahydroacridines: synthesis and biological evaluation.
Tripathi RP; Verma SS; Pandey J; Agarwal KC; Chaturvedi V; Manju YK; Srivastva AK; Gaikwad A; Sinha S
Bioorg Med Chem Lett; 2006 Oct; 16(19):5144-7. PubMed ID: 16870429
[TBL] [Abstract][Full Text] [Related]
32. Novel N'-benzylidene benzofuran-3-carbohydrazide derivatives as antitubercular and antifungal agents.
Telvekar VN; Belubbi A; Bairwa VK; Satardekar K
Bioorg Med Chem Lett; 2012 Mar; 22(6):2343-6. PubMed ID: 22365752
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides.
Daryaee F; Kobarfard F; Khalaj A; Farnia P
Eur J Med Chem; 2009 Jan; 44(1):289-95. PubMed ID: 18436347
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines.
Tripathi RP; Saxena N; Tiwari VK; Verma SS; Chaturvedi V; Manju YK; Srivastva AK; Gaikwad A; Sinha S
Bioorg Med Chem; 2006 Dec; 14(24):8186-96. PubMed ID: 17010617
[TBL] [Abstract][Full Text] [Related]
36. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
[TBL] [Abstract][Full Text] [Related]
38. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
39. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.
Saquib M; Gupta MK; Sagar R; Prabhakar YS; Shaw AK; Kumar R; Maulik PR; Gaikwad AN; Sinha S; Srivastava AK; Chaturvedi V; Srivastava R; Srivastava BS
J Med Chem; 2007 Jun; 50(13):2942-50. PubMed ID: 17542574
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives.
Das SK; Panda G; Chaturvedi V; Manju YS; Gaikwad AK; Sinha S
Bioorg Med Chem Lett; 2007 Oct; 17(20):5586-9. PubMed ID: 17764933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
